Open AccessMalignancies in systemic lupus erythematosus
Author(s) -
G.C. Goobie,
Sasha Bernatsky,
Rosalind RamseyGoldman,
Ann E. Clarke
Publication year - 2015
Publication title -
current opinion in rheumatology/current opinion in rheumatology, with evaluated medline
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 1.452
H-Index - 112
eISSN - 1080-8175
pISSN - 1040-8711
DOI - 10.1097/bor.0000000000000202
Subject(s) - medicine , malignancy , prostate cancer , lymphoma , systemic lupus erythematosus , breast cancer , cancer , immunology , autoantibody , lung cancer , population , oncology , disease , antibody , environmental health
Patients with systemic lupus erythematosus (SLE) have altered incidences of certain malignancies as compared with the general population. This review summarizes the recent literature on risk of malignancy in SLE and proposed mechanisms for these altered susceptibilities.